Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Hepatitis C

  Free Subscription


Articles published in Enferm Infecc Microbiol Clin

Retrieve available abstracts of 18 articles:
HTML format
Text format



Single Articles


    February 2018
  1. ALVAREZ PAREDES L, Buzon Martin L, Ortega Lafont M, Moran Rodriguez MA, et al
    Spontaneous bacterial peritonitis due to Helicobacter pylori in a cirrhotic patient with human immunodeficiency virus and hepatitis C virus coinfection.
    Enferm Infecc Microbiol Clin. 2018 Feb 8. pii: S0213-005X(17)30389.
    PubMed     Text format    


    December 2017
  2. REQUENA-HERRERA MP, Bedoya-Ismodes EO, Soto A
    Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection.
    Enferm Infecc Microbiol Clin. 2017 Dec 15. pii: S0213-005X(17)30372.
    PubMed     Text format    


  3. LLENAS-GARCIA J, Padilla S, Masia M, Gutierrez F, et al
    Sofosbuvir plus daclatasvir as an alternative for patients on haemodialysis with genotype 2 hepatitis C virus infection.
    Enferm Infecc Microbiol Clin. 2017 Dec 4. pii: S0213-005X(17)30306.
    PubMed     Text format    


    June 2017
  4. MORENO-PLANAS JM, Larrubia-Marfil JR, Sanchez-Ruano JJ, Morillas-Arino J, et al
    Influence of baseline MELD score in the efficacy of treatment of hepatitis C with simeprevir and sofosbuvir.
    Enferm Infecc Microbiol Clin. 2017 Jun 19. pii: S0213-005X(17)30139.
    PubMed     Text format     Abstract available


    May 2017
  5. PALLADINO C, Esteban-Cartelle B, Mate-Cano I, Sanchez-Carrillo M, et al
    Prevalence of relevant NS5A resistance-associated substitutions to elbasvir in genotype 1a hepatitis C virus patients in Spain.
    Enferm Infecc Microbiol Clin. 2017 May 15. pii: S0213-005X(17)30126.
    PubMed     Text format     Abstract available


    March 2017
  6. PANIAGUA-GARCIA M, Lopez-Hernandez I, Fernandez-Cuenca F, Rios-Villegas MJ, et al
    Acute fulminant hepatitis B during hepatitis C virus therapy with direct-acting antivirals in a patient co-infected with HIV.
    Enferm Infecc Microbiol Clin. 2017 Mar 30. pii: S0213-005X(17)30097.
    PubMed     Text format    


    February 2017
  7. ALONSO R, Perez-Garcia F, Lopez-Roa P, Alcala L, et al
    HCV core-antigen assay as an alternative to HCV RNA quantification: A correlation study for the assessment of HCV viremia.
    Enferm Infecc Microbiol Clin. 2017 Feb 25. pii: S0213-005X(16)30394.
    PubMed     Text format     Abstract available


  8. LOPEZ-FABAL M FEMININE, Perez-Rivilla A, Gomez-Garces JL
    Evaluation of sera with a low signal to cut-off ratio using two chemiluminescent assays for detecting Hepatitis C Virus, and their correlation with the detection of Viral RNA.
    Enferm Infecc Microbiol Clin. 2017 Feb 23. pii: S0213-005X(17)30025.
    PubMed     Text format     Abstract available


    January 2017
  9. AGUINAGA A, Diaz-Gonzalez J, Perez-Garcia A, Barrado L, et al
    [The prevalence of diagnosed and undiagnosed hepatitis C virus infection in Navarra, Spain, 2014-2016].
    Enferm Infecc Microbiol Clin. 2017 Jan 19. pii: S0213-005X(16)30401.
    PubMed     Text format     Abstract available


    September 2016
  10. MEIJIDE H, Mena A, Rodriguez-Osorio I, Pertega S, et al
    Trends in hospital admissions, re-admissions, and in-hospital mortality among HIV-infected patients between 1993 and 2013: Impact of hepatitis C co-infection.
    Enferm Infecc Microbiol Clin. 2016 Sep 5. pii: S0213-005X(16)30242.
    PubMed     Text format     Abstract available


    July 2016
  11. MEDINA GONZALEZ R, Orta Mira N, Guna Serrano Mdel R, Latorre Martinez JC, et al
    [Analysis of the results of the HIV-1, HCV and HBV viral load of SEIMC External Quality Control Program. Year 2014].
    Enferm Infecc Microbiol Clin. 2016;34 Suppl 3:8-13.
    PubMed     Text format     Abstract available


    April 2016
  12. CRESPO M, Navarro J, Moreno S, Sanz J, et al
    Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group.
    Enferm Infecc Microbiol Clin. 2016 Apr 6. pii: S0213-005X(16)30028.
    PubMed     Text format     Abstract available


    March 2016
  13. DOMINGUEZ-DOMINGUEZ L, de Lagarde-Sebastian M, de Miguel-Campo B, Pulido F, et al
    [Streptococcus salivarius spontaneous bacterial peritonitis in a HIV/HCV-co-infected patient treated with direct antiviral agents].
    Enferm Infecc Microbiol Clin. 2016 Mar 15. pii: S0213-005X(16)00079.
    PubMed     Text format    


    February 2016
  14. BERNAL-SORIANO MC, Gimeno A, Sanchez-Paya J, Portilla J, et al
    [Influence of sample conservation on quantification of Hepatitis C Virus RNA].
    Enferm Infecc Microbiol Clin. 2016 Feb 1. pii: S0213-005X(16)00016.
    PubMed     Text format    


    October 2015
  15. BARBERIA-MARCALAIN E, Xifro-Collsamata A, Arroyo-Fernandez A, Medallo-Muniz J, et al
    [Prevalence of human inmunodeficiency virus and hepatitis C virus markers in forensic autopsy cases in Barcelona and Lleida].
    Enferm Infecc Microbiol Clin. 2015 Oct 16. pii: S0213-005X(15)00319.
    PubMed     Text format    



  16. Executive summary of the consensus document on post-exposure prophylaxis against HIV, HBV and HCV in adults and children.
    Enferm Infecc Microbiol Clin. 2015 Oct 13. pii: S0213-005X(15)00312.
    PubMed     Text format     Abstract available


    September 2015

  17. [Consensus Document on post-exposure prophylaxis against HIV, HBV and HCV in adults and children].
    Enferm Infecc Microbiol Clin. 2015 Sep 22. pii: S0213-005X(15)00313.
    PubMed     Text format     Abstract available


    July 2015
  18. ORTA MIRA N, Del Remedio Guna Serrano M, Latorre Martinez JC, Medina Gonzalez R, et al
    [Analysis of the results of the HIV-1, HCV and HBV viral load of SEIMC External Quality Control Program. Year 2013].
    Enferm Infecc Microbiol Clin. 2015;33 Suppl 2:9-14.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: